Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126170591 | 12617059 | 1 | I | 20160725 | 20160803 | 20160803 | EXP | GB-DEXPHARM-20161652 | DEXCEL | 83.00 | YR | E | M | Y | 97.52000 | KG | 20160803 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126170591 | 12617059 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | U | 0 | ||||||||||
126170591 | 12617059 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126170591 | 12617059 | 1 | Blood cholesterol increased |
126170591 | 12617059 | 2 | Dyspepsia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126170591 | 12617059 | LT |
126170591 | 12617059 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126170591 | 12617059 | Amyloidosis | |
126170591 | 12617059 | Arthralgia | |
126170591 | 12617059 | Constipation | |
126170591 | 12617059 | Decreased appetite | |
126170591 | 12617059 | Dysgeusia | |
126170591 | 12617059 | Hypotension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126170591 | 12617059 | 1 | 201510 | 0 | ||
126170591 | 12617059 | 2 | 201510 | 0 |